Drugmaker GSK has today reaffirmed its outlook for 2025 and said it was "well positioned" to mitigate any hit from potential sector-specific tariffs, after first quarter results beat expectations.
Full Story
3,124,000 news articles indexed and analysed from 346 sources in 4 languages.
Articles and images are sorted, ranked and categorised automatically, placement is not intended to cause offence.
WireBeat accepts no liability for the content published by third parties.
English ¦ 
Spanish ¦ 
French ¦ 
German
© Accumudata Limited 2022 Release Version 1.22 Company Number: 12846061 All Rights Reserved.